0001688416-23-000002.txt : 20230420 0001688416-23-000002.hdr.sgml : 20230420 20230420140755 ACCESSION NUMBER: 0001688416-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230420 DATE AS OF CHANGE: 20230420 EFFECTIVENESS DATE: 20230420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioConsortia, Inc. CENTRAL INDEX KEY: 0001688416 IRS NUMBER: 464990266 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-479553 FILM NUMBER: 23832550 BUSINESS ADDRESS: STREET 1: 279 CONSTEAU PLACE STREET 2: SUITE 100 CITY: DAVIS STATE: CA ZIP: 95618 BUSINESS PHONE: 530-564-5572 MAIL ADDRESS: STREET 1: 279 CONSTEAU PLACE STREET 2: SUITE 100 CITY: DAVIS STATE: CA ZIP: 95618 D 1 primary_doc.xml X0708 D LIVE 0001688416 BioConsortia, Inc. 279 CONSTEAU PLACE SUITE 100 DAVIS CA CALIFORNIA 95618 530-564-5572 DELAWARE None None Corporation true Marcus Meadows-Smith 279 Consteau Place Suite 100 Davis CA CALIFORNIA 95618 Executive Officer Director Christina Huben 279 Consteau Place Suite 100 Davis CA CALIFORNIA 95618 Executive Officer John M. Pasquesi 279 Consteau Place Suite 100 Davis CA CALIFORNIA 95618 Director Other Decline to Disclose 06b false 2023-04-17 false true false 0 15000000 15000000 0 false 1 0 0 0 The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes. false BioConsortia, Inc. Christina E. Huben Christina E. Huben Chief Financial Officer 2023-04-20